Darlene Griffith is a man serving a prison sentence for a home invasion. He was on hormone treatment when he entered the system consisting of Premarin, 2.5 mg; Medroxyprogesterone, 2 ml; and Delestrogen, .3 ml. Griffith advised the prison that he was taking the hormones for Gender Identity Disorder (“GID”) and that discontinuing the treatment would cause him physical and mental harm. The court concluded that he was not denied treatment for his GID when he entered the system; he was given Estrogen immediately upon his entry into the system and was provided with some form of hormone therapy throughout his incarceration. Thus, the court dismissed his lawsuit for deliberate indifferent under the 8th Amendment.
Gender Identity Watch supports the rights of individuals to have their GID medications continued in prison for GID treatment started prior to incarceration. Most recently, the U.S. Court of Appeals for the 11th Circuit affirmed the right of incarcerated persons to have their GID medications continued while incarcerated.